Zamyl: Phase III

PDLI said that in a U.S. study of 191 patients with AML, the combination of its Zamyl humanized antibody with chemotherapy did not

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE